Eric W Nodiff Net Worth

The estimated Net Worth of Eric W Nodiff is at least $3.99 Million dollars as of 10 April 2018. Eric Nodiff owns over 1,275 units of Cantel Medical Corp stock worth over $2,991,373 and over the last 8 years Eric sold CMD stock worth over $996,997.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Eric Nodiff CMD stock SEC Form 4 insiders trading

Eric has made over 6 trades of the Cantel Medical Corp stock since 2017, according to the Form 4 filled with the SEC. Most recently Eric sold 2,906 units of CMD stock worth $269,996 on 28 September 2018.

The largest trade Eric's ever made was selling 2,906 units of Cantel Medical Corp stock on 28 September 2018 worth over $269,996. On average, Eric trades about 711 units every 41 days since 2016. As of 10 April 2018 Eric still owns at least 36,650 units of Cantel Medical Corp stock.

You can see the complete history of Eric Nodiff stock trades at the bottom of the page.

What's Eric Nodiff's mailing address?

Eric's mailing address filed with the SEC is CANTEL MEDICAL CORP., 150 CLOVE ROAD, LITTLE FALLS, NJ, 07424.

Insiders trading at Cantel Medical Corp

Over the last 9 years, insiders at Cantel Medical Corp have traded over $17,499,798 worth of Cantel Medical Corp stock and bought 37,750 units worth $1,679,440 . The most active insiders traders include Anthony B Evnin, Karen Prange, and Charles M Diker. On average, Cantel Medical Corp executives and independent directors trade stock every 39 days with the average trade being worth of $640,554. The most recent stock trade was executed by Ann E Berman on 5 April 2021, trading 5,500 units of CMD stock currently worth $453,255.

What does Cantel Medical Corp do?

Complete history of Eric Nodiff stock trades at Cantel Medical Corp

Cantel Medical Corp executives and stock owners

Cantel Medical Corp executives and other stock owners filed with the SEC include:

• George L. Fotiades,
  CEO, Vice Chairman & Member of Office of the Chairman
• Peter G. Clifford,
  Pres & COO
• Seth M. Yellin,
  Exec. VP of Strategy & Corp. Devel.
• Shaun M. Blakeman,
  Sr. VP, CFO & Member of Office of the Chairman
• Charles Michael Diker,
  Chairman & Member of Office of the Chairman
• Jeffrey Z. Mann,
  Sr. VP, Gen. Counsel, Corp. Sec. & Member of Office of the Chairman
• Jean M. Casner,
  Sr. VP & Chief HR Officer
• Milicent Brooks,
  Head of Corp. Communications
• Ryan Lada,
  VP of Investor Relations
• Michael Drexel,
  CTO & Sr. VP
• Jean Casner,
  SVP and CHRO
• Dorothy A Donnelly Brienza,
  
• Eric W Nodiff,
  EVP and General Counsel
• Anthony B Evnin,
  Director
• Steven C Anaya,
  SVP; Chief Accounting Officer
• Mark N. Diker,
  Director
• Laura L Forese,
  Director
• Alan R Batkin,
  Director
• Ronnie Myers,
  Director
• Ann E Berman,
  Director
• Brian Capone,
  SVP and Princ. Accounting Ofr
• Jorgen B Hansen,
  President and CEO
• Seth M Yellin,
  Executive Vice President
• Peter Pronovost,
  Director
• Lawrence Conway,
  Senior Vice President
• Shaun M. Blakeman,
  SVP - CFO
• Jeffrey Z Mann,
  SVP, General Counsel
• Karen Prange,
  Director
• George L Fotiades,
  Chief Executive Officer
• Peter G Clifford,
  President and COO
• Charles M Diker,
  Chairman